End-Stage Renal Disease: Medicare Payments for All ESRD Services, Including Injectable Drugs, Should Be Bundled
GAO-07-266T
Published: Dec 06, 2006. Publicly Released: Dec 06, 2006.
Skip to Highlights
Highlights
This testimony discusses highlights from GAO's report entitled "End-Stage Renal Disease: Bundling Medicare's Payment for Drugs with Payment for All ESRD Services Would Promote Efficiency and Clinical Flexibility." The report examines Medicare payments for certain drugs provided to patients with end-stage renal disease (ESRD), a condition of permanent kidney failure.
Full Report
Office of Public Affairs
Topics
Blood diseasesCost analysisDialysisFood and drug lawMedicarePaymentsPolicy evaluationPrescription drugsPrices and pricingProgram evaluationRatesUrologic diseasesProgram goals or objectives